Shimizu K - Search Results

1

Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients.

Evans R, Kimura H, Alexander R, Davies CH, Faessel H, Hartman DS, Ishikawa T, Ratti E, Shimizu K, Suzuki M, Tanaka S, Yukitake H, Dauvilliers Y, Mignot E. Evans R, et al. Among authors: shimizu k. Proc Natl Acad Sci U S A. 2022 Aug 30;119(35):e2207531119. doi: 10.1073/pnas.2207531119. Epub 2022 Aug 22. Proc Natl Acad Sci U S A. 2022. PMID: 35994639 Free PMC article.

2

A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension.

Rakugi H, Shimizu K, Nishiyama Y, Sano Y, Umeda Y. Rakugi H, et al. Among authors: shimizu k. Blood Press. 2018 Jun;27(3):125-133. doi: 10.1080/08037051.2017.1412797. Epub 2017 Dec 13. Blood Press. 2018. PMID: 29235365 Clinical Trial.

3

Effects of triple combination therapy with azilsartan/amlodipine/hydrochlorothiazide on office/home blood pressure: a randomized-controlled trial in Japanese essential hypertensive patients.

Rakugi H, Shimizu K, Sano Y, Nishiyama Y, Kinugawa Y, Terashio S. Rakugi H, et al. Among authors: shimizu k. Blood Press Monit. 2018 Apr;23(2):91-102. doi: 10.1097/MBP.0000000000000308. Blood Press Monit. 2018. PMID: 29239867 Clinical Trial.

4

Pharmacokinetics, safety, and tolerability of sodium phenylacetate and sodium benzoate in healthy Japanese volunteers: A phase I, single-center, open-label study.

Endo F, Nakamura K, Sano Y, Dote N, Shimizu K, Koumura E. Endo F, et al. Among authors: shimizu k. Drug Metab Pharmacokinet. 2023 Feb;48:100474. doi: 10.1016/j.dmpk.2022.100474. Epub 2022 Sep 8. Drug Metab Pharmacokinet. 2023. PMID: 36529053 Free article.

5

Efficacy and safety of trelagliptin in Japanese patients with type 2 diabetes with severe renal impairment or end-stage renal disease: Results from a randomized, phase 3 study.

Kaku K, Ishida K, Shimizu K, Achira M, Umeda Y. Kaku K, et al. Among authors: shimizu k. J Diabetes Investig. 2020 Mar;11(2):373-381. doi: 10.1111/jdi.13126. Epub 2019 Sep 19. J Diabetes Investig. 2020. PMID: 31389201 Free PMC article. Clinical Trial.

6

Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria: A Randomized, Controlled Trial.

Ito S, Kagawa T, Saiki T, Shimizu K, Kuroda S, Sano Y, Umeda Y. Ito S, et al. Among authors: shimizu k. Clin J Am Soc Nephrol. 2019 Mar 7;14(3):354-363. doi: 10.2215/CJN.07720618. Epub 2019 Feb 12. Clin J Am Soc Nephrol. 2019. PMID: 30755452 Free PMC article. Clinical Trial.

7

Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.

Kakimoto Y, Hoshino M, Hashimoto M, Hiraizumi M, Shimizu K, Chou T. Kakimoto Y, et al. Among authors: shimizu k. Intern Med. 2022 May 1;61(9):1337-1343. doi: 10.2169/internalmedicine.7768-21. Epub 2021 Oct 12. Intern Med. 2022. PMID: 34645759 Free PMC article.

8

Pharmacokinetics and Safety After a Single Dose of Imarikiren in Subjects with Renal or Hepatic Impairment.

Shimasaki Y, Sakaki M, Itou M, Kobayashi T, Aso M, Kagawa T, Saiki T, Matsuno K, Sano Y, Shimizu K, Kuroda S, Koumura E. Shimasaki Y, et al. Among authors: shimizu k. Clin Drug Investig. 2018 Nov;38(11):1041-1051. doi: 10.1007/s40261-018-0695-4. Clin Drug Investig. 2018. PMID: 30194585 Clinical Trial.

9

Severe hypoglycemia with reduced liver volume as an indicator of end-stage malnutrition in patients with anorexia nervosa: a retrospective observational study.

Matsunaga H, Riku K, Shimizu K, Fujimi S. Matsunaga H, et al. Among authors: shimizu k. J Eat Disord. 2024 May 3;12(1):55. doi: 10.1186/s40337-024-01011-1. J Eat Disord. 2024. PMID: 38702806 Free PMC article.

10

Improving hemocompatibility of decellularized vascular tissue by structural modification of collagen fiber.

Mahara A, Ota S, Le HT, Shimizu K, Soni R, Kojima K, Hirano Y, Kakinoki S, Yamaoka T. Mahara A, et al. Among authors: shimizu k. Int J Biol Macromol. 2024 May 1;269(Pt 1):132040. doi: 10.1016/j.ijbiomac.2024.132040. Online ahead of print. Int J Biol Macromol. 2024. PMID: 38702003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,171 results

Search Page